OHSU President Danny Jacobs, M.D., M.P.H., shared this message with the OHSU community on Monday, Dec. 12, 2022.
Dear OHSU Community,
It is my pleasure to announce that I have appointed David Jacoby, M.D., dean of the OHSU School of Medicine, effective immediately. Dr. Jacoby brings extensive leadership experience and significant contributions to our clinical, education and research missions over his 20-year tenure at OHSU. His deep knowledge of, and relationships across, OHSU and the School of Medicine will serve us at a time of great complexity and promise.
Dr. Jacoby joined OHSU as chief of pulmonary and critical care in 2003, and led the expansion of that division in patient care, research, and education. He became interim chair of the department of medicine in 2017 and permanent chair in 2018. He is professor of medicine, and chemical physiology and biochemistry, in the OHSU School of Medicine, and has served as interim dean of the school since October 2021.
Since 2008, he has directed the M.D./Ph.D. program, training the next generation of physician-scientists who advance medicine from the bench to the bedside. He has led the expansion of this program and established our NIH Medical Scientist Training Program grant in 2016, renewing this last year. Dr. Jacoby has won multiple house staff and graduate student teaching awards at OHSU and fostered a scientific culture in the Pulmonary and Critical Care Fellowship Program, establishing that program’s NIH T32 training grant in 2008 (this grant has now been renewed twice).
Dr. Jacoby maintains an active research program that has been continuously funded by the NIH since 1990. His research focuses on airway pharmacology and abnormalities of airway nerves in asthma, as well as the role of eosinophils in airway disease. He has trained 21 students and fellows in his lab, many of whom remain in research positions in academia and industry around the country.
As a pulmonologist and intensivist, Dr. Jacoby attends in the Medical Intensive Care Unit (MICU). During the pandemic, he said seeing the efforts of the broad multidisciplinary team in taking care of desperately ill COVID-19 patients filled him with pride in our organization.
And when our expenses to meet the needs of our state and patients began dramatically outpacing our revenues, at my request he partnered with OHSU Health CEO Dr. John Hunter to identify and operationalize approaches to ensure OHSU’s viability for the long term.
Dr. Jacoby received his bachelor’s degree from Princeton University, his medical degree from New York Medical College, and was a resident and chief resident in internal medicine at Temple University Hospital in Philadelphia. He then did a pulmonary fellowship at University of California, San Francisco, and a research fellowship with Dr. Jay Nadel in the UCSF Cardiovascular Research Institute. Subsequently, Dr. Jacoby spent 13 years at Johns Hopkins, where he served as research director for the Division of Pulmonary and Critical Care, and was Firm Faculty, a designation reserved for faculty most involved in-house staff education. He was elected to the American Society for Clinical Investigation in 2000 and was promoted to full professor with tenure at Johns Hopkins in 2002.
Dr. Jacoby asked me to share this message with you: “I am very grateful for this opportunity and for the confidence that Dr. Jacobs has placed in me. I very much look forward to continuing to work with him and with the OHSU executive leadership team. I thank everyone in the School of Medicine for your support over the past year, and I hope and plan to justify this support going forward. In particular, I want to thank the Department Chairs and the Dean’s Office team. I have relied on your guidance and wisdom. And I have never been disappointed.”
Please join me in congratulating Dr. Jacoby.
Danny Jacobs, M.D., M.P.H., FACS